Treatment
Mesenchymal Stem Cells clinical trials
We’re tracking 124 recruiting studies that include Mesenchymal Stem Cells, each written for real people, not researchers, below.
Recruiting studies
- NCT07441226RecruitingPhase 2
Stem cells for advanced COPD treatment
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
Jakarta, Jakarta Special Capital RegionAges 40–75 - NCT07480161RecruitingPhase 2/Phase 3
Stem cell and exosome therapy for diabetic erectile dysfunction
This trial tests whether a treatment made from stem cells and their cell messengers (exosomes) can help men with diabetes and erectile dysfunction who have not been helped by standard treatments. The goal is to see if this therapy can improve erections and offer a less invasive option than a penile implant.
Ankara, AnkaraAges 25–75 - NCT07512362RecruitingPhase 2
Stem cells and antibodies for early Alzheimer's disease
This study tests whether human stem cells, combined with your existing Alzheimer's medication (Leqembi or Kisunla), can help slow memory loss and improve daily functioning in people with mild cognitive impairment or early Alzheimer's. You would receive a stem cell infusion as an add-on to your current treatment.
Miami, FloridaAges 55–90 - NCT07580755Recruiting
Stem cells to help burn wounds heal after skin grafting
This trial tests whether mesenchymal stem cells (a type of healing cell) can help burn wounds recover better when combined with skin grafting. The goal is to improve how well the grafted skin takes and heals.
Xinxiang, HenanAges 18–65 - NCT07623382RecruitingEarly Phase 1
Stem Cell Treatment for Dry Eye Disease
This early-stage trial tests whether special cells derived from umbilical cord tissue can help treat dry eye disease. The treatment uses tiny particles called extracellular vesicles that may reduce eye dryness and improve comfort.
Xiamen, ChinaAges 18 years+ - NCT07635758RecruitingPhase 1/Phase 2
Stem Cell Treatment for Recent Stroke Recovery
This trial tests whether special cells from human placenta can help your brain recover after a recent stroke. The treatment is given as an injection and aims to reduce long-term disability.
BeijingAges 18–80 - NCT06888973Enrolling by invitationPhase 1/Phase 2
Stem cell infusion for autoimmune diseases
This clinical trial is testing if infusions of special stem cells (called mesenchymal stem cells) can help people with certain autoimmune diseases where standard treatments have not worked well enough. It is an early-phase study in Pakistan for adults (and some children for one condition) with rheumatoid arthritis, lupus, systemic sclerosis, ankylosing spondylitis, or dermatomyositis/polymyositis.
RawalpindiAges 18–50 - NCT06764329Enrolling by invitationPhase 1/Phase 2
Stem cell therapy for male hair loss
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
RawalpindiAges 20–59 - NCT04650568Enrolling by invitation
Stem cell treatment after ACL ligament surgery
This trial studies whether adding mesenchymal stem cells during ACL (knee ligament) reconstruction helps the knee heal better. You might be eligible if your ACL injury is recent and you’re having a specific type of graft surgery.
Chicago, IllinoisAges 18–60 - NCT06435897RecruitingPhase 1/Phase 2
MSC and CAR-T cell therapy for autoimmune disease
This trial tests a new treatment using a combination of two types of immune cells (MSCs and CAR-T cells) to calm the immune system and treat autoimmune diseases. It may help people whose autoimmune condition is not well controlled with current medications.
Shenzhen, GuangdongAges 18–75 - NCT07498218RecruitingPhase 1
Studying VELGRAFT for diabetic foot ulcers
This trial tests a new treatment called VELGRAFT, which is made from living cells, for diabetic foot ulcers that haven't healed with standard care. The goal is to see if it can help the wound close and heal more effectively.
Phoenix, ArizonaAges 18 years+ - NCT07471074Recruiting
Study of stem cells in Waldenström macroglobulinemia
This study looks at bone marrow stem cells in people with Waldenström macroglobulinemia (WM). It aims to understand how these cells work and may help improve future treatments for WM.
AmiensAges 18 years+ - NCT06488898RecruitingPhase 2
Cell therapy to stabilize large abdominal aortic aneurysm
This trial tests whether a special cell treatment can help stabilize a large abdominal aortic aneurysm (AAA) instead of just watching it grow. You may qualify if your aneurysm is at least 5 cm wide and you are scheduled for standard endovascular repair.
MadridAges 18 years+ - NCT07077746RecruitingPhase 2
Stem cells for Crohn's disease
This trial tests whether a type of stem cell called HB-adMSCs can help treat Crohn's disease. It is for adults with mild to moderate Crohn's who have certain signs of inflammation in their blood and recent imaging of their condition.
Sugar Land, TexasAges 18–65 - NCT05018858RecruitingPhase 1
Test stem cell infusion safety for lupus
This early-phase study tests whether an intravenous (through a vein) stem cell treatment made from donated umbilical cord tissue is safe for people with lupus. It focuses mainly on side effects and how well participants tolerate the infusion.
St John'sAges Any age - NCT05224960RecruitingPhase 2
Stem cell treatment for worsening liver cirrhosis
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
Lanzhou, GansuAges 18–75 - NCT03123458Enrolling by invitationPhase 1
Stem cell treatment to calm immune problems
This Phase 1 study tests an early-stage “clonal” fetal stem cell treatment to help control immune-related disorders like graft-versus-host disease (GVHD). It may help people whose immune symptoms are hard to control, but it is carefully limited to certain medical situations.
Shenzhen, GuangdongAges 1–80 - NCT04476901RecruitingPhase 2
Study of donor stem cell treatment for non-ischemic heart failure
This Phase 2 trial tests whether donor “MSC” cells can improve heart function in people with non-ischemic dilated cardiomyopathy and reduced pumping strength. You may be eligible if your condition is already treated with standard heart medicines and you can safely undergo a heart catheterization and follow-up testing.
Stanford, CaliforniaAges 18–80 - NCT05018767RecruitingPhase 1
Testing an IV stem cell treatment for aging frailty safety
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
St John'sAges Any age - NCT07374679Recruiting
Long-term safety and effectiveness of stem cells for rotator cuff disease
This study follows up with people who already received an experimental stem cell treatment for rotator cuff disease in a previous trial. It aims to check if the treatment remains safe and effective over time.
Seoul, KoreaAges 19 years+ - NCT07265349RecruitingPhase 1/Phase 2
Stem cells plus bypass surgery for chronic heart failure
This trial tests whether injecting stem cells from umbilical cord tissue into the heart muscle during bypass surgery can improve heart function in people with chronic heart failure. It is for patients who are already scheduled for bypass surgery and have a weakened heart pump (LVEF between 21% and 40%).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07183761RecruitingPhase 2
Stem cell therapy for diabetic nerve pain
This study tests whether umbilical cord stem cells can help people with diabetic nerve damage in their legs who haven't gotten enough relief from standard treatments. It aims to improve symptoms like numbness, pain, and tingling.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT06817616Recruiting
Rotator cuff repair with stem cells for large shoulder tears
This trial tests whether adding umbilical cord stem cells to standard arthroscopic rotator cuff repair helps heal large or massive tears better. It may be an option if you have had shoulder pain for at least three months and other treatments haven't worked.
Seoul, KoreaAges 19 years+ - NCT06610773RecruitingPhase 1/Phase 2
Stem cell treatment for high-risk HPV infection
This trial tests whether umbilical cord stem cells can help clear a persistent high-risk HPV infection. It is for women aged 25 to 60 who have had HPV for a while and have not been treated with other HPV drugs recently.
Shanghai, Shanghai MunicipalityAges 25–60
Common questions
- Are there clinical trials studying Mesenchymal Stem Cells?
- Yes. Clin2 currently lists 124 recruiting studies that include Mesenchymal Stem Cells, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Mesenchymal Stem Cells trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Mesenchymal Stem Cells an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Mesenchymal Stem Cells or a specific trial is right for you.
Related treatments
- Human Umbilical Cord Mesenchymal Stem Cells
- Umbilical Cord Mesenchymal Stem Cell
- Mesenchymal Stromal Cells
- Mesenchymal Stem Cell
- Umbilical Cord Blood-Derived Stem Cells and Exosomes
- Base-edited hematopoietic stem and progenitor cells
- Β-globin Restored Autologous Hematopoietic Stem Cells
- CAR-T cells
- CD19 CAR-T cells
- anti-CD19 CAR-T cells
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.